These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 8281363)

  • 21. Blood lipids profile in obese or overweight patients.
    Szczygielska A; Widomska S; Jaraszkiewicz M; Knera P; Muc K
    Ann Univ Mariae Curie Sklodowska Med; 2003; 58(2):343-9. PubMed ID: 15323217
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cholesterol and coronary events. The current thinking.
    Jones PH
    Postgrad Med; 2003 Apr; 113(4 Suppl):5-14. PubMed ID: 19667618
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Apparent protective effect of high density lipoprotein against coronary heart disease in the elderly.
    Li JZ; Chen ML; Wang S; Dong J; Zeng P; Hou LW
    Chin Med J (Engl); 2004 Apr; 117(4):511-5. PubMed ID: 15109440
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of pravastatin on coronary events in 2073 patients with low levels of both low-density lipoprotein cholesterol and high-density lipoprotein cholesterol: results from the LIPID study.
    Colquhoun D; Keech A; Hunt D; Marschner I; Simes J; Glasziou P; White H; Barter P; Tonkin A;
    Eur Heart J; 2004 May; 25(9):771-7. PubMed ID: 15120888
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cholesterol and coronary heart disease: predicting risks in men by changes in levels and ratios.
    Kinosian B; Glick H; Preiss L; Puder KL
    J Investig Med; 1995 Oct; 43(5):443-50. PubMed ID: 8528755
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prevalence of high plasma triglyceride combined with low HDL-C levels and its association with smoking, hypertension, obesity, diabetes, sedentariness and LDL-C levels in the Canadian population. Canadian Heart Health Surveys Research Group.
    Connelly PW; Petrasovits A; Stachenko S; MacLean DR; Little JA; Chockalingam A
    Can J Cardiol; 1999 Apr; 15(4):428-33. PubMed ID: 10322252
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Assessing risk factors of coronary heart disease and its risk prediction among Korean adults: the 2001 Korea National Health and Nutrition Examination Survey.
    Ko M; Kim MT; Nam JJ
    Int J Cardiol; 2006 Jun; 110(2):184-90. PubMed ID: 16412525
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prevalence of coronary heart disease and risk factors in an urban Indian population: Jaipur Heart Watch-2.
    Gupta R; Gupta VP; Sarna M; Bhatnagar S; Thanvi J; Sharma V; Singh AK; Gupta JB; Kaul V
    Indian Heart J; 2002; 54(1):59-66. PubMed ID: 11999090
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dyslipidemia and coronary artery disease.
    Genest JG
    Can J Cardiol; 2000 Jan; 16 Suppl A():3A-4A. PubMed ID: 10653923
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Importance of LDL/HDL cholesterol ratio as a predictor for coronary heart disease events in patients with heterozygous familial hypercholesterolaemia: a 15-year follow-up (1987-2002).
    Panagiotakos DB; Pitsavos C; Skoumas J; Chrysohoou C; Toutouza M; Stefanadis CI; Toutouzas PK
    Curr Med Res Opin; 2003; 19(2):89-94. PubMed ID: 12755140
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A tertiary care hospital-based study of conventional risk factors including lipid profile in proven coronary artery disease.
    Goel PK; Bharti BB; Pandey CM; Singh U; Tewari S; Kapoor A; Garg N; Sinha N
    Indian Heart J; 2003; 55(3):234-40. PubMed ID: 14560932
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Plasma levels of cholesteryl ester transfer protein and the risk of future coronary artery disease in apparently healthy men and women: the prospective EPIC (European Prospective Investigation into Cancer and nutrition)-Norfolk population study.
    Boekholdt SM; Kuivenhoven JA; Wareham NJ; Peters RJ; Jukema JW; Luben R; Bingham SA; Day NE; Kastelein JJ; Khaw KT
    Circulation; 2004 Sep; 110(11):1418-23. PubMed ID: 15337694
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Coronary heart disease risk factors among blood donors in northwest Ethiopia.
    Gebre-Yohannes A; Rahlenbeck SI
    East Afr Med J; 1998 Sep; 75(9):495-500. PubMed ID: 10493048
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Risk determination of dyslipidemia in populations characterized by low levels of high-density lipoprotein cholesterol.
    Bersot TP; Pépin GM; Mahley RW
    Am Heart J; 2003 Dec; 146(6):1052-9. PubMed ID: 14660998
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Risks of estrogens in the prevention of osteoporosis].
    Kruyver GP
    Ned Tijdschr Geneeskd; 1986 Jul; 130(27):1246. PubMed ID: 3736702
    [No Abstract]   [Full Text] [Related]  

  • 36. Treatment of the climacteric.
    Hunter DJ
    Practitioner; 1977 Oct; 219(1312):564-70. PubMed ID: 594013
    [No Abstract]   [Full Text] [Related]  

  • 37. [Estrogens and cancer risk. Practical consequences for estrogen therapy].
    Kaiser R
    MMW Munch Med Wochenschr; 1978 Sep; 120(37):1185-6. PubMed ID: 308177
    [No Abstract]   [Full Text] [Related]  

  • 38. Oestrogens and postprandial lipid metabolism.
    Westerveld HT; Meyer E; de Bruin TW; Erkelens DW
    Biochem Soc Trans; 1997 Feb; 25(1):45-9. PubMed ID: 9056841
    [No Abstract]   [Full Text] [Related]  

  • 39. [Hazards of oral contraception using estroprogestational steroids].
    Mauvais-Jarvis P; de Lignieres B; Bercovici JP
    Presse Med (1893); 1969 Oct; 77(41):1419-22. PubMed ID: 5345791
    [No Abstract]   [Full Text] [Related]  

  • 40. Exogenous estrogens: a continuing controversy.
    Malkasian GD
    Geriatrics; 1982 Mar; 37(3):79-81, 85-6, 88. PubMed ID: 7067978
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.